Stifel Financial Corp Precision Biosciences Inc Transaction History

Stifel Financial Corp

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 12, 2024	BUY	$0.29 - $0.45 $6,383 - $9,904	22,011 Added 1.44%	1,545,850 $556,000
Q3 2023 Nov 13, 2023	SELL	$0.34 - $0.69 $147,911 - $300,172	-435,033 Reduced 22.21%	1,523,839 $518,000
Q2 2023 Aug 14, 2023	BUY	$0.52 - $0.91 $545,880 - $955,291	1,049,771 Added 115.47%	1,958,872 $1.04 Million
Q1 2023 May 12, 2023	SELL	$0.7 - $1.41 $24,008 - $48,360	-34,298 Reduced 3.64%	909,101 $681,000
Q4 2022 Feb 13, 2023	BUY	$0.97 - $45.0 $239,953 - $11.1 Million	247,375 Added 35.54%	943,399 $1.12 Million
Q3 2022 Nov 14, 2022	SELL	$1.22 - $40.8 $34,963 - $1.17 Million	-28,659 Reduced 3.95%	696,024 $905,000
Q2 2022 Aug 15, 2022	BUY	$1.15 - $3.34 $697,209 - $2.02 Million	606,269 Added 511.99%	724,683 $1.16 Million
Q1 2022 May 13, 2022	BUY	$2.96 - $7.76 $350,505 - $918,892	118,414 New	118,414 $365,000

2.56M

Ticker DTIL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 110,818,000
Market Cap $521M
Description
Precision BioSciences, Inc., a clinical stage gene editing company, develops in vivo gene editing and ex vivo allogeneic CAR T therapies in the United States. It offers ARCUS, a genome editing platform to cure genetic disorders. The company also provides Ex vivo Allogeneic CAR T Immunotherapy, a form of immunotherapy in which T cell, a specific ...

Get notified when there are updates to the investment portfolio of Stifel Financial Corp, based on Form 13F filings with the SEC.

Stay updated on Stifel Financial Corp with notifications on news.